Pseudophenmetrazine

Pseudophenmetrazine is a stimulant drug of the morpholine class. It is a positional isomer of phenmetrazine, differing in the position of the methyl group on the morpholine ring. Pseudophenmetrazine has been studied for its potential use in the treatment of obesity and attention deficit hyperactivity disorder (ADHD).
Chemical Structure and Properties[edit]
Pseudophenmetrazine is chemically known as 3-methyl-2-phenylmorpholine. It is a structural isomer of phenmetrazine, with the methyl group located at the 3-position of the morpholine ring instead of the 2-position. This slight structural difference results in different pharmacological properties.
Pharmacology[edit]
Pseudophenmetrazine acts as a central nervous system (CNS) stimulant. It is believed to work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. This action is similar to that of other stimulant drugs, which can lead to increased alertness, concentration, and energy levels.
Medical Uses[edit]
Pseudophenmetrazine has been investigated for its potential use in the treatment of obesity and ADHD. However, it is not currently approved for medical use in most countries. Its effects on weight loss and attention improvement are thought to be due to its stimulant properties, which can suppress appetite and enhance focus.
Side Effects[edit]
As with other stimulant drugs, pseudophenmetrazine can cause a range of side effects. Common side effects may include insomnia, dry mouth, increased heart rate, and anxiety. More severe side effects can include hypertension, cardiovascular problems, and potential for substance abuse.
Legal Status[edit]
The legal status of pseudophenmetrazine varies by country. In some regions, it may be classified as a controlled substance due to its potential for abuse and addiction. It is important to check local regulations before obtaining or using this substance.
See Also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
